Tesla (NASDAQ:TSLA) edges higher in after-hours trading, having hit another record high, at $265, in Wednesday’s regular trading session, after it files to sell $1.6 billion in convertible debt. Of the total offering, the luxury electric car maker will offer $800 million aggregate principal amount of convertible senior notes due 2019 and $800 million aggregate…
Autodesk Inc. (NASDAQ:ADSK) rose 4.2% in extended trading after reporting earnings that beat analyst estimates. The software company’s Q4 earnings fell 25% from a year earlier to $0.40 a share, beating the Capital IQ estimate of $0.34. Revenue slipped 3.4% from a year earlier $586.6 million, beating the consensus estimate of $571 million. Autodesk estimated…
Fourth-quarter and anticipated future results for demand, retention, pricing, and expenses came in well above very low expectations for Strayer Eductation (NASDAQ:STRA), which should lead to significant upward moves in consensus forward earnings estimates. When combined with very weak sentiment following four years of virtually uninterrupted bad news and an associated 91% decline in peak-to-trough…
Animated film company DreamWorks Animation SKG (NASDAQ:DWA) is down 13% to $30.57 per share on heavy volume of 4 million shares following a rating cut at Piper Jaffray to Underperform from Neutral. The analyst firm maintained a price target of $19 per share on DWA. The downgrade follows disappointing 4Q revenue reported after Tuesday’s close…
Real estate investment trust American Tower (NYSE:AMT) is preparing a bid for an Indian telecommunications tower company, Viom Networks, that could amount to $1.6 billion to $1.9 billion, according to the Economic Times, an Indian newspaper. Citing unnamed sources, the Times said the bid may come by March 7, and that American Tower is likely…
Aegerion Pharmaceuticals (NASDAQ:AEGR) is lower after it reported a Q4 loss that was smaller than analysts had expected and set a FY14 sales guidance that straddled estimates. Shares are down 11.48% at $58.73 with a 52-week range of $28.33 – $101.00. In the quarter, the biopharmaceutical company had a non-GAAP loss of $0.14 per share,…
Tech Analysis & Market News